Home›Stock Screener›Concord Drugs›P/E Ratio

Concord Drugs P/E Ratio

Current P/E Ratio
49.31
High Valuation
Very High - High growth expectations or significantly overvalued

Concord Drugs P/E ratio. Concord Drugs (CONCORD) P/E ratio is 49.31 (High), EPS (TTM) ₹0.95, current price ₹73.03 on BSE vs historical average P/E of 97.64 (50.0th percentile) — Very High - High growth expectations or significantly overvalued. Also explore CONCORD price trends to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 49.31
Current Price ₹73.03
EPS (TTM) ₹0.95
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 97.64
Historical Range 33.56 - 161.73
Percentile 50.0%

Sector Context

Sector Average 56.23
Sector Median 32.41
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹1.55
Mar 2026 ₹0.47
Jun 2026 ₹0.85

CONCORD P/E Ratio — Valuation Signal & Historical Context

Concord Drugs P/E 49.31 vs historical average 97.64, range 33.56–161.73 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Concord Drugs share price screener.

  • Stock appears overvalued with PE of 49.31, suggesting caution for new investments
  • Current PE is 49.5% below historical average
  • Trading at discount to sector average PE of 56.23

Concord Drugs P/E Ratio Historical Trend

CONCORD annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 49.31 vs historical average 97.64. Examine CONCORD quarterly trends for recent quarterly revenue, profit and EPS trends.

CONCORD Historical P/E Ratio — EPS, Year-End Price & Valuation

Concord Drugs annual P/E ratio, EPS (₹), year-end price and valuation category on BSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 161.73 0.51 ₹82.48 BSE High
2022 33.56 0.97 ₹32.55 BSE High

CONCORD vs Healthcare Peers — P/E Ratio Comparison

Concord Drugs P/E 49.31 vs Healthcare average 56.23, median 32.41 — range 2.04–740.29.

Sector Average
56.23
Sector Median
32.41
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low